Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

During a live event, Matthew Galsky, MD discussed neoadjuvant and adjuvant options for a patient case including nivolumab or ...

Neoadjuvant and adjuvant therapy administration, according to the Rocky Mountain ... “Everybody today that has stage 2 bladder cancer and received treatment before the surgery should ask their medical ...

The extent of residual prostate cancer in the surgical specimen following intensified neoadjuvant therapy for high-risk localized prostate cancer may predict metastatic recurrence. Residual ...

SunRISe-4 looked at the combination of TAR-200 with cetrelimab as neoadjuvant (pre ... in non–muscle-invasive bladder cancer (NMIBC) unresponsive to first-line therapy with BCG, achieving ...

Neoadjuvant chemotherapy specifically refers to chemotherapy administered before your primary treatment, which may be surgery or radiation therapy ... removing all your cancer cells.

Imfinzi is approved in combination with gemcitabine and cisplatin as a neoadjuvant treatment for muscle-invasive bladder cancer (MIBC ... at least one prior therapy, but not approved for any ...

For a patient with locally advanced lung cancer, the benefits of neoadjuvant chemoimmunotherapy should stand regardless of the destination of local therapy. The responses to chemoimmunotherapy that we ...

neoadjuvant chemotherapy ... (surgery to remove the bladder) has been approved in the US for the treatment of adult patients with muscle-invasive bladder cancer (MIBC). The approval was granted ...